Cetera Advisor Networks LLC Zynerba Pharmaceuticals, Inc. Transaction History

Cetera Advisor Networks LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.33 - $1.39 $1,758 - $7,408	-5,330 Reduced 19.41%	22,124 $28,000
Q2 2023 Aug 09, 2023	BUY	$0.3 - $0.43 $958 - $1,373	3,194 Added 13.17%	27,454 $9,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $0.72 $13 - $18	-26 Reduced 0.11%	24,260 $12,000
Q3 2022 Nov 10, 2022	SELL	$0.87 - $1.36 $103 - $161	-119 Reduced 0.49%	24,286 $18,000
Q2 2022 Aug 11, 2022	BUY	$0.86 - $2.06 $20,988 - $50,274	24,405 New	24,405 $28,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.